-+ 0.00%
-+ 0.00%
-+ 0.00%

ENvue Medical Launches Development And Integration Program Leveraging Vibration-Based Technology From NanoVibronix Division To Address Pain, Discomfort Linked With Indwelling NG Tubes

Benzinga·01/09/2026 14:05:01
Listen to the news

ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing on the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a new development and integration program leveraging vibration-based technology from its NanoVibronix division to address pain and discomfort associated with indwelling nasogastric (NG) tubes.

Nasogastric tubes are among the most widely used devices in hospital care and are frequently required to remain in place for extended periods. While clinically essential, indwelling NG tubes are commonly associated with nasal and throat discomfort during the dwell phase, an issue for which limited mitigation options currently exist.